📅October 11 – 14
After a three years gap, the ESGCT congress is back! The annual congress of the European Society for Gene & Cell therapy is known for its cutting-edge science, up-to-date programme and its focus on enabling in-depth networking and collaborations. Furthermore, this year’s annual congress is being held in collaboration with the British Society for Gene and Cell Therapy (BSGCT).
The event will be held in Edinburgh and Asphalion will be there! Asphalion experts Oriol Penon, Chris Mann and Jon Giblin will attend the congress. They will be available at BOOTH #56 to present you Asphalion and all the solutions we can provide you with, as well as to discuss all your regulatory needs.
At Asphalion we have extensive experience in providing a comprehensive assistance for pharma and biotech companies to address the challenges that may arise during product development and registration of Advanced Therapy Medicinal Products (ATMPs), including the following: strategic roadmaps, regulatory procedures, engagement with EMA, NCAs and FDA, clinical trials with ATMPs submissions, GMOs, feasibility assessment, among others.
If you want to schedule a meeting, you can send an email at: [email protected]
Looking forward to meet you in Edinburgh!
